What is a stock summary page? Click here for an overview.
Business Description
Vaxil Bio Ltd
NAICS : 325412
SIC : 3741
ISIN : CA92243L1076
Description
Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.9 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 46.4 | |||||
| 3-Year FCF Growth Rate | 30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10 | |||||
| Quick Ratio | 10 | |||||
| Cash Ratio | 6.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -15.81 | |||||
| ROA % | -14 | |||||
| ROIC % | -68.33 | |||||
| ROCE % | -16.66 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | -3.28 | |||||
| EV-to-EBITDA | -3.28 | |||||
| EV-to-FCF | -2 | |||||
| Price-to-Net-Current-Asset-Value | 1 | |||||
| Earnings Yield (Greenblatt) % | -30.49 | |||||
| FCF Yield % | -16.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vaxil Bio Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.008 | ||
| Beta | -0.02 | ||
| 3-Year Sharpe Ratio | -0.05 | ||
| 3-Year Sortino Ratio | -0.11 | ||
| Volatility % | 33.33 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (C$) | 0.000007 | ||
| 20-Day SMA (C$) | 0.01 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (C$) | 0.005 - 0.015 | ||
| Shares Outstanding (Mil) | 136.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vaxil Bio Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vaxil Bio Ltd Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vaxil Bio Ltd Frequently Asked Questions
What is Vaxil Bio Ltd(TSXV:VXL)'s stock price today?
The current price of TSXV:VXL is C$0.01. The 52 week high of TSXV:VXL is C$0.02 and 52 week low is C$0.01.
When is next earnings date of Vaxil Bio Ltd(TSXV:VXL)?
The next earnings date of Vaxil Bio Ltd(TSXV:VXL) is .
Does Vaxil Bio Ltd(TSXV:VXL) pay dividends? If so, how much?
Vaxil Bio Ltd(TSXV:VXL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers